New triple therapy targets hard-to-treat breast cancers
Disease control
Ongoing
This study tests a combination of three drugs—cisplatin, romidepsin, and nivolumab—in people with advanced triple-negative breast cancer or BRCA-related breast cancer that has spread. The goal is to see if the combination can shrink tumors and control the disease. About 51 partic…
Phase: PHASE1, PHASE2 • Sponsor: Priyanka Sharma • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC